Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Using meta-regression in performing indirect-comparisons: comparing escitalopram with venlafaxine XR.

Eckert L, Falissard B.

Curr Med Res Opin. 2006 Nov;22(11):2313-21.

PMID:
17076991
2.
4.

[Escitalopram for treatment of major depressive disorder in adults].

Llorca PM, Brousse G, Schwan R.

Encephale. 2005 Jul-Aug;31(4 Pt 1):490-501. Review. French.

PMID:
16389716
5.

Bupropion: a review of its use in the management of major depressive disorder.

Dhillon S, Yang LP, Curran MP.

Drugs. 2008;68(5):653-89. Review. Erratum in: Drugs. 2008;68(7):980.

PMID:
18370448
6.

Escitalopram therapy for major depression and anxiety disorders.

Baldwin DS, Reines EH, Guiton C, Weiller E.

Ann Pharmacother. 2007 Oct;41(10):1583-92. Epub 2007 Sep 11. Review.

PMID:
17848424
7.

Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder.

Hansen RA, Gartlehner G, Lohr KN, Gaynes BN, Carey TS.

Ann Intern Med. 2005 Sep 20;143(6):415-26. Review.

PMID:
16172440
8.

[Severe forms of depression: the efficacy of escitalopram].

Spadone C.

Encephale. 2009 Apr;35(2):152-9. doi: 10.1016/j.encep.2008.09.008. Epub 2009 Mar 31. Review. French.

PMID:
19393384
9.

A non-inferiority comparison of duloxetine and venlafaxine in the treatment of adult patients with generalized anxiety disorder.

Allgulander C, Nutt D, Detke M, Erickson J, Spann M, Walker D, Ball S, Russell J.

J Psychopharmacol. 2008 Jun;22(4):417-25. doi: 10.1177/0269881108091588.

PMID:
18635722
10.

Spotlight on bupropion in major depressive disorder.

Dhillon S, Yang LP, Curran MP.

CNS Drugs. 2008;22(7):613-7. Review.

PMID:
18547129
11.

Which antidepressants have demonstrated superior efficacy? A review of the evidence.

Montgomery SA, Baldwin DS, Blier P, Fineberg NA, Kasper S, Lader M, Lam RW, Lépine JP, Möller HJ, Nutt DJ, Rouillon F, Schatzberg AF, Thase ME.

Int Clin Psychopharmacol. 2007 Nov;22(6):323-9. Review. Erratum in: Int Clin Psychopharmacol. 2008 Jan;23(1):61.

PMID:
17917550
12.

[Antidepressants and their onset of action: a major clinical, methodological and pronostical issue].

Gourion D.

Encephale. 2008 Jan;34(1):73-81. doi: 10.1016/j.encep.2007.12.001. Epub 2008 Feb 5. Review. French.

PMID:
18514154
13.

Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians.

Gartlehner G, Gaynes BN, Hansen RA, Thieda P, DeVeaugh-Geiss A, Krebs EE, Moore CG, Morgan L, Lohr KN.

Ann Intern Med. 2008 Nov 18;149(10):734-50. Review.

PMID:
19017592
14.

Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis.

Smith D, Dempster C, Glanville J, Freemantle N, Anderson I.

Br J Psychiatry. 2002 May;180:396-404. Review.

15.

Managing depressive and anxiety disorders with escitalopram.

Thase ME.

Expert Opin Pharmacother. 2006 Mar;7(4):429-40. Review.

PMID:
16503815
17.

Efficacy and tolerability of second-generation antidepressants in social anxiety disorder.

Hansen RA, Gaynes BN, Gartlehner G, Moore CG, Tiwari R, Lohr KN.

Int Clin Psychopharmacol. 2008 May;23(3):170-9. doi: 10.1097/YIC.0b013e3282f4224a. Review.

18.

Frequency of treatment-effect modification affecting indirect comparisons: a systematic review.

Coory M, Jordan S.

Pharmacoeconomics. 2010;28(9):723-32. doi: 10.2165/11535670-000000000-00000. Review.

PMID:
20545383
19.

Indirect comparisons of treatments based on systematic reviews of randomised controlled trials.

Edwards SJ, Clarke MJ, Wordsworth S, Borrill J.

Int J Clin Pract. 2009 Jun;63(6):841-54. doi: 10.1111/j.1742-1241.2009.02072.x. Review.

PMID:
19490195
20.

[Indirect comparison and network meta-analyses--new tools for the assessment of evidence on the relative efficacy of drugs].

Peura P, Asseburg C, Turunen J, Purmonen T, Martikainen J.

Duodecim. 2011;127(9):900-10. Review. Finnish.

PMID:
21648163

Supplemental Content

Support Center